BRISTOL-MYERS SQUIBB COMPANY Payments for Restructuring
BRISTOL-MYERS SQUIBB COMPANY (BMY) reported Payments for Restructuring of $221.00 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-07-30.
Financial Statements › Cash Flow › Financing Activities
us-gaap:PaymentsForRestructuring · last filed 2026-07-30
- BRISTOL-MYERS SQUIBB COMPANY payments for restructuring for the quarter ending 2026-06-30 was $78.00M, a 52.73% decline year-over-year.
- BRISTOL-MYERS SQUIBB COMPANY payments for restructuring for the quarter ending 2026-03-31 was $143.00M, a 1.38% decline year-over-year.
- BRISTOL-MYERS SQUIBB COMPANY payments for restructuring for the quarter ending 2025-12-31 was $106.00M, a 20.45% increase year-over-year.
- BRISTOL-MYERS SQUIBB COMPANY payments for restructuring for the quarter ending 2025-09-30 was $142.00M, a 28.28% decline year-over-year.
- BRISTOL-MYERS SQUIBB COMPANY payments for restructuring for fiscal 2025 was $558.00M, a 7.31% increase from fiscal 2024.
- BRISTOL-MYERS SQUIBB COMPANY payments for restructuring for fiscal 2024 was $520.00M, a 131.11% increase from fiscal 2023.
- BRISTOL-MYERS SQUIBB COMPANY payments for restructuring for fiscal 2023 was $225.00M, a 84.43% increase from fiscal 2022.
- BRISTOL-MYERS SQUIBB COMPANY payments for restructuring for fiscal 2022 was $122.00M, a 38.69% decline from fiscal 2021.
| Period end | Payments for Restructuring 3 month | Payments for Restructuring 6 month | Payments for Restructuring 9 month | Payments for Restructuring 12 month |
|---|---|---|---|---|
| 2026-06-30 | $78.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-07-30 | $221.00M 10-Q · filed 2026-07-30 | $327.00M derived: sum of 3 quarters · filed 2026-07-30 | $469.00M derived: sum of 4 quarters · filed 2026-07-30 |
| 2026-03-31 | $143.00M 10-Q · filed 2026-04-30 | $249.00M derived: sum of 2 quarters · filed 2026-04-30 | $391.00M derived: sum of 3 quarters · filed 2026-04-30 | $556.00M derived: sum of 4 quarters · filed 2026-07-30 |
| 2025-12-31 | $106.00M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-11 | $248.00M derived: sum of 2 quarters · filed 2026-02-11 | $413.00M derived: sum of 3 quarters · filed 2026-07-30 | $558.00M 10-K · filed 2026-02-11 |
| 2025-09-30 | $142.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-10-30 | $307.00M derived: sum of 2 quarters · filed 2026-07-30 | $452.00M 10-Q · filed 2025-10-30 | $540.00M derived: sum of 4 quarters · filed 2026-07-30 |
| 2025-06-30 | $165.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-07-30 | $310.00M 10-Q · filed 2026-07-30 | $398.00M derived: sum of 3 quarters · filed 2026-07-30 | $596.00M derived: sum of 4 quarters · filed 2026-07-30 |
| 2025-03-31 | $145.00M 10-Q · filed 2026-04-30 | $233.00M derived: sum of 2 quarters · filed 2026-04-30 | $431.00M derived: sum of 3 quarters · filed 2026-04-30 | $568.00M derived: sum of 4 quarters · filed 2026-04-30 |
| 2024-12-31 | $88.00M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-11 | $286.00M derived: sum of 2 quarters · filed 2026-02-11 | $423.00M derived: sum of 3 quarters · filed 2026-02-11 | $520.00M 10-K · filed 2026-02-11 |
| 2024-09-30 | $198.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-10-30 | $335.00M derived: sum of 2 quarters · filed 2025-10-30 | $432.00M 10-Q · filed 2025-10-30 | $515.00M derived: sum of 4 quarters · filed 2025-10-30 |
| 2024-06-30 | $137.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-07-31 | $234.00M 10-Q · filed 2025-07-31 | $317.00M derived: sum of 3 quarters · filed 2025-07-31 | $411.00M derived: sum of 4 quarters · filed 2025-07-31 |
| 2024-03-31 | $97.00M 10-Q · filed 2025-04-24 | $180.00M derived: sum of 2 quarters · filed 2025-04-24 | $274.00M derived: sum of 3 quarters · filed 2025-04-24 | $305.00M derived: sum of 4 quarters · filed 2025-04-24 |
| 2023-12-31 | $83.00M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-12 | $177.00M derived: sum of 2 quarters · filed 2025-02-12 | $208.00M derived: sum of 3 quarters · filed 2025-02-12 | $225.00M 10-K · filed 2025-02-12 |
| 2023-09-30 | $94.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-10-31 | $125.00M derived: sum of 2 quarters · filed 2024-10-31 | $142.00M 10-Q · filed 2024-10-31 | $158.00M derived: sum of 4 quarters · filed 2024-10-31 |
| 2023-06-30 | $31.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-07-26 | $48.00M 10-Q · filed 2024-07-26 | $64.00M derived: sum of 3 quarters · filed 2024-07-26 | $103.00M derived: sum of 4 quarters · filed 2024-07-26 |
| 2023-03-31 | $17.00M 10-Q · filed 2024-04-25 | $33.00M derived: sum of 2 quarters · filed 2024-04-25 | $72.00M derived: sum of 3 quarters · filed 2024-04-25 | $118.00M derived: sum of 4 quarters · filed 2024-04-25 |
| 2022-12-31 | $16.00M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-13 | $55.00M derived: sum of 2 quarters · filed 2024-02-13 | $101.00M derived: sum of 3 quarters · filed 2024-02-13 | $122.00M 10-K · filed 2024-02-13 |
| 2022-09-30 | $39.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-10-26 | $85.00M derived: sum of 2 quarters · filed 2023-10-26 | $106.00M 10-Q · filed 2023-10-26 | $135.00M derived: sum of 4 quarters · filed 2023-10-26 |
| 2022-06-30 | $46.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-07-27 | $67.00M 10-Q · filed 2023-07-27 | $96.00M derived: sum of 3 quarters · filed 2023-07-27 | $132.00M derived: sum of 4 quarters · filed 2023-07-27 |
| 2022-03-31 | $21.00M 10-Q · filed 2023-04-27 | $50.00M derived: sum of 2 quarters · filed 2023-04-27 | $86.00M derived: sum of 3 quarters · filed 2023-04-27 | $220.00M derived: sum of 4 quarters · filed 2023-04-27 |
| 2021-12-31 | $29.00M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-14 | $65.00M derived: sum of 2 quarters · filed 2023-02-14 | $199.00M derived: sum of 3 quarters · filed 2023-02-14 | $199.00M 10-K · filed 2023-02-14 |
| 2021-09-30 | $36.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-10-26 | $170.00M derived: sum of 2 quarters · filed 2022-10-26 | $170.00M 10-Q · filed 2022-10-26 | $352.00M derived: sum of 4 quarters · filed 2022-10-26 |
| 2021-06-30 | $134.00M 10-Q · filed 2021-07-28 | $134.00M 10-Q · filed 2022-07-27 | $316.00M derived: sum of 3 quarters · filed 2022-04-29 | |
| 2021-03-31 | $59.00M 10-Q · filed 2022-04-29 | $182.00M derived: sum of 2 quarters · filed 2022-04-29 | ||
| 2020-12-31 | $123.00M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-09 | $418.00M 10-K · filed 2022-02-09 | ||
| 2020-09-30 | $295.00M 10-Q · filed 2021-10-27 | |||
| 2020-06-30 | $188.00M 10-Q · filed 2021-07-28 | $295.00M derived: sum of 2 quarters · filed 2021-07-28 | $348.00M derived: sum of 3 quarters · filed 2022-02-09 | $372.00M derived: sum of 4 quarters · filed 2022-02-09 |
| 2020-03-31 | $107.00M 10-Q · filed 2021-04-29 | $160.00M derived: sum of 2 quarters · filed 2022-02-09 | $184.00M derived: sum of 3 quarters · filed 2022-02-09 | $213.00M derived: sum of 4 quarters · filed 2022-02-09 |
| 2019-12-31 | $53.00M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-09 | $77.00M derived: sum of 2 quarters · filed 2022-02-09 | $106.00M derived: sum of 3 quarters · filed 2022-02-09 | $151.00M 10-K · filed 2022-02-09 |
| 2019-09-30 | $24.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-10-31 | $53.00M derived: sum of 2 quarters · filed 2019-10-31 | $98.00M 10-Q · filed 2019-10-31 | $146.00M derived: sum of 4 quarters · filed 2021-02-10 |
| 2019-06-30 | $29.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-07-25 | $74.00M 10-Q · filed 2019-07-25 | $122.00M derived: sum of 3 quarters · filed 2021-02-10 | $164.00M derived: sum of 4 quarters · filed 2021-02-10 |
| 2019-03-31 | $45.00M 10-Q · filed 2019-04-25 | $93.00M derived: sum of 2 quarters · filed 2021-02-10 | $135.00M derived: sum of 3 quarters · filed 2021-02-10 | $189.00M derived: sum of 4 quarters · filed 2021-02-10 |
| 2018-12-31 | $48.00M derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-10 | $90.00M derived: sum of 2 quarters · filed 2021-02-10 | $144.00M derived: sum of 3 quarters · filed 2021-02-10 | $219.00M 10-K · filed 2021-02-10 |
| 2018-09-30 | $42.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-10-31 | $96.00M derived: sum of 2 quarters · filed 2019-10-31 | $171.00M 10-Q · filed 2019-10-31 | $231.00M derived: sum of 4 quarters · filed 2019-10-31 |
| 2018-06-30 | $54.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-07-25 | $129.00M 10-Q · filed 2019-07-25 | $189.00M derived: sum of 3 quarters · filed 2019-07-25 | $263.00M derived: sum of 4 quarters · filed 2019-07-25 |
| 2018-03-31 | $75.00M 10-Q · filed 2019-04-25 | $135.00M derived: sum of 2 quarters · filed 2019-04-25 | $209.00M derived: sum of 3 quarters · filed 2019-04-25 | $270.00M derived: sum of 4 quarters · filed 2019-04-25 |
| 2017-12-31 | $60.00M derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-25 | $134.00M derived: sum of 2 quarters · filed 2019-02-25 | $195.00M derived: sum of 3 quarters · filed 2019-02-25 | $239.00M 10-K · filed 2019-02-25 |
| 2017-09-30 | $74.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2018-10-25 | $135.00M derived: sum of 2 quarters · filed 2018-10-25 | $179.00M 10-Q · filed 2018-10-25 | $211.00M derived: sum of 4 quarters · filed 2019-02-25 |
| 2017-06-30 | $61.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2018-07-26 | $105.00M 10-Q · filed 2018-07-26 | $137.00M derived: sum of 3 quarters · filed 2019-02-25 | $161.00M derived: sum of 4 quarters · filed 2019-02-25 |
| 2017-03-31 | $44.00M 10-Q · filed 2018-04-26 | $76.00M derived: sum of 2 quarters · filed 2019-02-25 | $100.00M derived: sum of 3 quarters · filed 2019-02-25 | $131.00M derived: sum of 4 quarters · filed 2019-02-25 |
| 2016-12-31 | $32.00M derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-25 | $56.00M derived: sum of 2 quarters · filed 2019-02-25 | $87.00M derived: sum of 3 quarters · filed 2019-02-25 | $120.00M 10-K · filed 2019-02-25 |
| 2016-09-30 | $24.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2017-10-26 | $55.00M derived: sum of 2 quarters · filed 2017-10-26 | $88.00M 10-Q · filed 2017-10-26 | $122.00M derived: sum of 4 quarters · filed 2018-02-13 |
| 2016-06-30 | $31.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2017-07-27 | $64.00M 10-Q · filed 2017-07-27 | $98.00M derived: sum of 3 quarters · filed 2018-02-13 | $119.00M derived: sum of 4 quarters · filed 2018-02-13 |
| 2016-03-31 | $33.00M 10-Q · filed 2017-04-27 | $67.00M derived: sum of 2 quarters · filed 2018-02-13 | $88.00M derived: sum of 3 quarters · filed 2018-02-13 | $122.00M derived: sum of 4 quarters · filed 2018-02-13 |
| 2015-12-31 | $34.00M derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-13 | $55.00M derived: sum of 2 quarters · filed 2018-02-13 | $89.00M derived: sum of 3 quarters · filed 2018-02-13 | $134.00M 10-K · filed 2018-02-13 |
| 2015-09-30 | $21.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2015-10-27 | $55.00M derived: sum of 2 quarters · filed 2015-10-27 | $100.00M 10-Q · filed 2015-10-27 | $134.00M derived: sum of 4 quarters · filed 2017-02-21 |
| 2015-06-30 | $34.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2015-07-23 | $79.00M 10-Q · filed 2015-07-23 | $113.00M derived: sum of 3 quarters · filed 2017-02-21 | $138.00M derived: sum of 4 quarters · filed 2017-02-21 |
| 2015-03-31 | $45.00M 10-Q · filed 2015-04-28 | $79.00M derived: sum of 2 quarters · filed 2017-02-21 | $104.00M derived: sum of 3 quarters · filed 2017-02-21 | $125.00M derived: sum of 4 quarters · filed 2017-02-21 |
| 2014-12-31 | $34.00M derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-21 | $59.00M derived: sum of 2 quarters · filed 2017-02-21 | $80.00M derived: sum of 3 quarters · filed 2017-02-21 | $107.00M 10-K · filed 2017-02-21 |
| 2014-09-30 | $25.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2015-10-27 | $46.00M derived: sum of 2 quarters · filed 2015-10-27 | $73.00M 10-Q · filed 2015-10-27 | $110.00M derived: sum of 4 quarters · filed 2016-02-12 |
| 2014-06-30 | $21.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2015-07-23 | $48.00M 10-Q · filed 2015-07-23 | $85.00M derived: sum of 3 quarters · filed 2016-02-12 | $146.00M derived: sum of 4 quarters · filed 2016-02-12 |
| 2014-03-31 | $27.00M 10-Q · filed 2015-04-28 | $64.00M derived: sum of 2 quarters · filed 2016-02-12 | $125.00M derived: sum of 3 quarters · filed 2016-02-12 | $197.00M derived: sum of 4 quarters · filed 2016-02-12 |
| 2013-12-31 | $37.00M derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-12 | $98.00M derived: sum of 2 quarters · filed 2016-02-12 | $170.00M derived: sum of 3 quarters · filed 2016-02-12 | $228.00M 10-K · filed 2016-02-12 |
| 2013-09-30 | $61.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2014-10-24 | $133.00M derived: sum of 2 quarters · filed 2014-10-24 | $191.00M 10-Q · filed 2014-10-24 | $234.00M derived: sum of 4 quarters · filed 2015-02-13 |
| 2013-06-30 | $72.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2014-07-24 | $130.00M 10-Q · filed 2014-07-24 | $173.00M derived: sum of 3 quarters · filed 2015-02-13 | |
| 2013-03-31 | $58.00M 10-Q · filed 2014-04-29 | $101.00M derived: sum of 2 quarters · filed 2015-02-13 | ||
| 2012-12-31 | $43.00M derived: 10-K 12 month − 10-Q 9 month · filed 2015-02-13 | $109.00M 10-K · filed 2015-02-13 | ||
| 2012-09-30 | $66.00M 10-Q · filed 2013-10-23 | |||
| 2011-12-31 | $167.00M 10-K · filed 2014-02-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| VERTEX PHARMACEUTICALS INC / MA (VRTX) | United States | $132.481B | 28.56 |
| PFIZER INC (PFE) | United States | $162.042B | 31.94 |
| ABBOTT LABORATORIES (ABT) | United States | $176.045B | 28.47 |
| REGENERON PHARMACEUTICALS, INC. (REGN) | United States | $74.751B | 21.53 |
| ALNYLAM PHARMACEUTICALS, INC. (ALNY) | United States | $33.420B | 54.94 |
| Zoetis Inc. (ZTS) | United States | $29.045B | 11.38 |
| INSMED Inc (INSM) | United States | $26.566B | -26.60 |
| Roivant Sciences Ltd. (ROIV) | $26.105B | -96.08 | |
| Royalty Pharma plc (RPRX) | United States | $22.628B | |
| UNITED THERAPEUTICS Corp (UTHR) | United States | $20.249B | 17.64 |